Tango Therapeutics TNGX Net Interest Income
Net Interest Income at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's net interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's net interest income?
- Tango Therapeutics (TNGX) reported net interest income of $2.18M in Q1 2026.
- How has Tango Therapeutics's net interest income changed year-over-year?
- Tango Therapeutics's net interest income increased by 34.9% year-over-year, from $1.61M to $2.18M.
- What is the long-term trend for Tango Therapeutics's net interest income?
- Over 4 years (2021 to 2025), Tango Therapeutics's net interest income has grown at a 83.6% compound annual growth rate (CAGR), from $495K to $5.63M.
- What does net interest income mean?
- This metric represents the difference between the interest income generated from interest-bearing assets and the interest expense incurred on interest-bearing liabilities. It serves as a measure of the profitability of a company's treasury management and financing activities. For non-financial firms, it highlights the net return on cash reserves and short-term investments.